INS and obesity due to melanocortin 4 receptor deficiency: FMT has been reported to treat obesity in mice [44], and Zhang et al. [45] showed that FMT improved some laboratory parameters (e.g., insulin sensitivity, glycated hemoglobin, etc.)in patients with metabolic syndrome, although none of the weight loss effects were significant.